Clinical trial
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic…
NCT00176293 · University of Kentucky, Other · Terminated
Key facts
| NCT number | NCT00176293 |
|---|---|
| Title | Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer |
| Official title | A Randomized Phase II Trial of Doxil With or Without Dexamethasone in Treatment of Patients With Metastatic Hormone Refractory Prostate Cancer |
| Lead sponsor | University of Kentucky, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | dexamethasone, doxorubicin |
| Enrollment | 2 |
| Start date | Oct 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: